首页 >
法规速递
-
Document: Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts-2025/4/10
2025-04-11查看详情 > -
Document: Overview of comments received on ICH M11 technical specification during second consultation (EMA/CHMP/ICH/778800/2022)-2025/5/23
2025-05-26查看详情 > -
Document: Annual activity report 2024-2025/6/27
2025-06-30查看详情 > -
Page: Dabrafenib product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
国家药监局药审中心关于发布《重组腺相关病毒载体类体内基因治疗产品申报上市药学共性问题与技术要求》的通告（2025年第39号）-2025/9/18
2025-09-19查看详情 > -
Document: Annex III - Written responses to list of issues - molecule-independent device bridging approach (MIDBA)-2025/10/24
2025-10-27查看详情 > -
Page: Type-II variations: questions and answers-2025/11/26
2025-11-27查看详情 > -
Document: Name Review Group form - questions and answers-2025/12/18
2025-12-19查看详情 > -
Document: Plasma Master File (PMF) requirements - questions and answers for PMF holders-2026/2/4
2026-02-05查看详情 > -
Document: CAT quarterly highlights and approved ATMPs - March 2026-2026/3/12
2026-03-13查看详情 >
